Recently many investigators (1, 2, 5, 7-10) reported on the immunohistochemical expression of some oncogenes in human tissues or tumors, but there have been few reports of the expression of the oncogene in small-sized-carcinomas.
The purpose of this study was to show the immunohistochemical activity of the commercialized antibodies of oncogene products and related enzymes using extremely small lesions of tubular adenocarcinomas in human stomachs.
MATERIALS AND METHODS
Every lesion of the gastric tubular adenocarcinomas in this study was found by chance during routine pathological examinations of surgically resected stomachs, and we re-examined them and measured them in maximum diameter using IBAS-2000 (Zeiss CO., LTD.). We used 11 carcinoma lesions measuring 1 mm in diameter and 8 carcinoma lesions measuring 1 5 mm in diameter (Table 1 , Fig.  1 ). These materials were fixed in 10% buffered formalin solution and embedded in paraffin.
The paraffin blocks including those carcinoma were completely sectioned to a thickness of 4 pm and stained with hematoxylin-eosin, c-myc oncogene products (6E10, C RB CO. , LTD.), c-erbB-2 gene product (Polyclonal antibody, Seikagaku Kogyo CO., LTD.), protein kinase C (Type III, Seikagaku Kogyo CO., LTD.) and lysozyme (DACO CO, LTD.) immunohistochemically by ABC method.
RESULTS (Table 1) Seven lesions among 11 carcinomas (63.6%) measuring 1 mm in diameter and 8 among 8 carcinoma lesions (100%) measuring 1 5 mm in diameter showed positive reactions in their cytoplasms for c-myc oncogene products (6E10) (Fig. 2) . In immunohistochemical staining for c-erbB-2 gene product Type III) immunohistochemically (x2 analysis, p<0.05) (Fig. 4) . All gastric minute tubular adenocarcinoma lesions in this study were positive in their cytoplasms for lysozyme immunohistochemically (Fig. 5) . cogene products and lysozyme immunohistochemically. Many investigators (1, 7, 9, 10) reported the expression of c-myc oncogene products in some tumors or normal tissues, but this report seems to be the first approach to the expression of c-myc oncogene products using minute gastric tubular adenocarcinomas. It was very interesting that extremely small gastric adenocarcinoma showed positive reaction for c-myc oncogene products immunohistochemically. Lysozyme is a well-known antibacterial enzyme and present in body excretions, such as tears and saliva (4). In the alimentary canal the pyloric glands, cardiac glands, mucous neck cells of the fundic glands in the stomach, Brunner glands in the duodenum and the glands of gallbladder are weakly positive in their cytoplasms for lysozyme. Paneth cells in the small intestine and intestinalized mucosa of the stomach are strongly positive in their cytoplasms for lysozyme immunohistochemically (2). Tahara et al. (11) described that the cases of lysozyme-positive advanced gastric carcinoma showed poorer prognosis in comparison with the lysozyme-negative cases. It is not, however, clear in this study why these minute gastric carcinimas showed lysozyme-activity.
There is a good chance that the lysozyme-activity is one of the essential characteristics of the gastric tubular adenocarcinoma.
The gastric tubular adenocarcinomas measuring 1 5 mm in diameter showed higher positive reaction for c-erbB-2 gene product and protein kinase C in their cytoplasms than those measuring up to 1 mm in diameter and also showed higher positive reaction in the expression of both c-myc oncogene products and lysozyme. Many investigators (2, 5, 8) reported the expression of c-erbB-2 gene product in some tumors or normal tissues. Several investigators (3, 6) pointed out that protein kinase C had some relationship to the tumor-promoting phorbolesters. The results in this study suggested that both c-erbB-2 gene product and protein kinase C have some relationship to the initial development of the gastric carcinoma. 
